320 related articles for article (PubMed ID: 18958538)
21. Dupuytren's disease characteristics in Primorsko-goranska County, Croatia.
Jurisić D; Ković I; Lulić I; Stanec Z; Kapović M; Uravić M
Coll Antropol; 2008 Dec; 32(4):1209-13. PubMed ID: 19149230
[TBL] [Abstract][Full Text] [Related]
22. A survey of clinical manifestations and risk factors in women with Dupuytren's disease.
Degreef I; Steeno P; De Smet L
Acta Orthop Belg; 2008 Aug; 74(4):456-60. PubMed ID: 18811027
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta: possible roles in Dupuytren's contracture.
Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
J Hand Surg Am; 1995 Jan; 20(1):101-8. PubMed ID: 7722248
[TBL] [Abstract][Full Text] [Related]
24. Co-ordinate expression of alpha 5 beta 1 integrin and fibronectin in Dupuytren's disease.
Magro G; Lanzafame S; Micali G
Acta Histochem; 1995 Jul; 97(3):229-33. PubMed ID: 8525780
[TBL] [Abstract][Full Text] [Related]
25. Beta-catenin expression in Dupuytren's disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro.
Varallo VM; Gan BS; Seney S; Ross DC; Roth JH; Richards RS; McFarlane RM; Alman B; Howard JC
Oncogene; 2003 Jun; 22(24):3680-4. PubMed ID: 12802275
[TBL] [Abstract][Full Text] [Related]
26. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
[TBL] [Abstract][Full Text] [Related]
27. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease.
Abe Y; Rokkaku T; Ofuchi S; Tokunaga S; Takahashi K; Moriya H
J Hand Surg Br; 2004 Oct; 29(5):427-30. PubMed ID: 15336743
[TBL] [Abstract][Full Text] [Related]
28. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
29. Results of total aponeurectomy for Dupuytren's contracture in 61 patients: a retrospective clinical study.
Högemann A; Wolfhard U; Kendoff D; Board TN; Olivier LC
Arch Orthop Trauma Surg; 2009 Feb; 129(2):195-201. PubMed ID: 18516613
[TBL] [Abstract][Full Text] [Related]
30. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue.
Tomasek JJ; Haaksma CJ
Anat Rec; 1991 Jun; 230(2):175-82. PubMed ID: 1867394
[TBL] [Abstract][Full Text] [Related]
31. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence.
Hindocha S; Stanley JK; Watson S; Bayat A
J Hand Surg Am; 2006 Dec; 31(10):1626-34. PubMed ID: 17145383
[TBL] [Abstract][Full Text] [Related]
32. A retrospective review of the management of Dupuytren's nodules.
Reilly RM; Stern PJ; Goldfarb CA
J Hand Surg Am; 2005 Sep; 30(5):1014-8. PubMed ID: 16182060
[TBL] [Abstract][Full Text] [Related]
33. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
[TBL] [Abstract][Full Text] [Related]
34. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
[TBL] [Abstract][Full Text] [Related]
35. Regulation of expression of alpha-smooth muscle actin in cells of Dupuytren's contracture.
Hindman HB; Marty-Roix R; Tang JB; Jupiter JB; Simmons BP; Spector M
J Bone Joint Surg Br; 2003 Apr; 85(3):448-55. PubMed ID: 12729127
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical evidence for Zic1 coexpression with beta-catenin in the myofibroblast of Dupuytren disease.
Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
Scand J Plast Reconstr Surg Hand Surg; 2009; 43(1):36-40. PubMed ID: 19153880
[TBL] [Abstract][Full Text] [Related]
37. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1.
Bisson MA; McGrouther DA; Mudera V; Grobbelaar AO
J Hand Surg Br; 2003 Aug; 28(4):351-6. PubMed ID: 12849947
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
39. beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression.
Shiratsuchi H; Nakashima T; Hirakawa N; Toh S; Nakagawa T; Saito T; Tsuneyoshi M; Komune S
Head Neck; 2007 Jun; 29(6):577-84. PubMed ID: 17315172
[TBL] [Abstract][Full Text] [Related]
40. Gene expression analysis of Dupuytren's disease: the role of TGF-beta2.
Zhang AY; Fong KD; Pham H; Nacamuli RP; Longaker MT; Chang J
J Hand Surg Eur Vol; 2008 Dec; 33(6):783-90. PubMed ID: 18694919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
